Trump’s 200% tariff threat could send shockwaves through pharma supply chains
Despite the threat of a 200% tariff, most pharma stocks remained stable.
10 July 2025
10 July 2025
Despite the threat of a 200% tariff, most pharma stocks remained stable.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.